We’re excited to welcome Natalia Novac as an Independent Board Director at VRG Therapeutics!

Natalia brings decades of leadership experience in pharma and biotech, having held impactful roles at Eli Lilly and Merck, served as a partner at Delin Ventures, and contributed her expertise to multiple biotech boards, including companies pioneering AI/ML platforms and therapeutic development.

With a strong foundation in oncology and immunology, her career spans drug discovery, development, commercialization, strategic management, business development and corporate investment.

Her expertise will be invaluable as we advance our mission to cure diseases via targets and mechanism of actions that cannot be reached with traditional approaches.

Welcome on board, Natalia!

‍